Banco Santander SA (SAN)

4.87
NYSE : Finance
Prev Close 4.87
Day Low/High 0.00 / 0.00
52 Wk Low/High 4.21 / 7.57
Avg Volume 8.68M
Exchange NYSE
Shares Outstanding 16.24B
Market Cap 79.05B
EPS 0.50
Div & Yield 0.20 (4.12%)

Latest News

Santander Bank Donates More Than $2 Million To Non-Profit Organizations In Final Round Of Funding In 2018

Santander Bank Donates More Than $2 Million To Non-Profit Organizations In Final Round Of Funding In 2018

BOSTON, Jan. 14, 2019 /PRNewswire/ -- Santander Bank today announced that it has donated more than $2 million to 66 non-profit organizations that support low- and moderate-income (LMI) individuals, families and communities primarily located in its...

Santander Bank Appoints Colleen Canny As Head Of The Retail Network

Santander Bank Appoints Colleen Canny As Head Of The Retail Network

BOSTON, Dec. 20, 2018 /PRNewswire/ -- Santander Bank today announced the appointment of Colleen Canny as head of its Retail Network.

Santander Bank Opens Newest Branch In Brooklyn

Santander Bank Opens Newest Branch In Brooklyn

Bank Donates $26,000 to Three Local Non-Profit Organizations to Celebrate its Expanding Presence in the Community

Sanofi To Transfer U.S. Stock Exchange Listing To Nasdaq

Sanofi To Transfer U.S. Stock Exchange Listing To Nasdaq

PARIS, Dec. 18, 2018 /PRNewswire/ -- Sanofi today announced that it will be transferring the listing of its American Depositary Shares (ADS) from the New York Stock Exchange (NYSE) to The Nasdaq Global Select Market (Nasdaq) effective December 31, 2018,...

Santander Bank Names Seth Goodall Executive Director, Corporate Social Responsibility

Santander Bank Names Seth Goodall Executive Director, Corporate Social Responsibility

BOSTON, Dec. 18, 2018 /PRNewswire/ -- Santander Bank today announced that it has named Seth Goodall as Executive Director, Corporate Social Responsibility.

Santander Bank Names David Harnisch Head Of Commercial Banking

Santander Bank Names David Harnisch Head Of Commercial Banking

Harnisch brings more than 25 years of financial services experience and accomplishments to the role

New England Journal Of Medicine Publishes Positive Detailed Results From Praluent® (alirocumab) Injection Cardiovascular Outcomes Trial

New England Journal Of Medicine Publishes Positive Detailed Results From Praluent® (alirocumab) Injection Cardiovascular Outcomes Trial

* Praluent significantly reduced major adverse cardiovascular events by 15% (p<0.001)

Santander Bank Opens First Branch In Flushing Neighborhood Of Queens

Santander Bank Opens First Branch In Flushing Neighborhood Of Queens

- Branch Features New Interior Design

Santander Successfully Launches Santander&reg; Enterprise Payment Link

Santander Successfully Launches Santander® Enterprise Payment Link

New Platform to Help Businesses Simplify and Digitize Payment Processing

Sanofi Q3 2018 Performance Confirms Return To Growth

Sanofi Q3 2018 Performance Confirms Return To Growth

PARIS , Oct. 31, 2018 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q3 2018 Change Change at CER 9M 2018 Change Change at CER IFRS net sales reported €9,392m +3.

FDA Grants Priority Review For Sanofi's Dengue Vaccine Candidate

FDA Grants Priority Review For Sanofi's Dengue Vaccine Candidate

BRIDGEWATER, N.J.

FDA Approves Asthsma Indication For Dupixent&reg; (dupilumab)

FDA Approves Asthsma Indication For Dupixent® (dupilumab)

-- Only biologic approved for both moderate and severe asthma patients with eosinophilic phenotype

Santander Bank Contributes Nearly $4 Million To 135 Non-Profit Organizations

Santander Bank Contributes Nearly $4 Million To 135 Non-Profit Organizations

$1 Million of Funding Supports Community Development Financial Institutions

Canadians Are Invited To Join The Conversation: Raise Your Hand For Diabetes

Canadians Are Invited To Join The Conversation: Raise Your Hand For Diabetes

LAVAL, QC, Oct. 17, 2018 /CNW Telbec/ - Sanofi Canada is on a mission to raise awareness and money to help people living with diabetes, one of the leading causes of death and disability in Canada.

Dupixent&reg; (dupilumab) Showed Positive Topline Results In Two Phase 3 Trials Of Patients With Chronic Rhinosinusitis With Nasal Polyps

Dupixent® (dupilumab) Showed Positive Topline Results In Two Phase 3 Trials Of Patients With Chronic Rhinosinusitis With Nasal Polyps

- Dupixent significantly reduced nasal polyp size, nasal congestion severity, and need for systemic corticosteroids and/or surgery

Santander Bank Expands Its Commercial Banking Business In The Southeast Region

Santander Bank Expands Its Commercial Banking Business In The Southeast Region

Commercial and Foreign Direct Investment Banking Experts Based in Miami

Santander Bank Celebrates Grand Opening Of Its Flagship Branch At 75 State Street

Santander Bank Celebrates Grand Opening Of Its Flagship Branch At 75 State Street

BOSTON, Oct. 4, 2018 /PRNewswire/ -- Santander Bank will celebrate the official re-opening of its flagship branch today following a redesign project that has transformed the space into a state-of-the-art destination in the heart of Boston's Financial...

Santander Bank Launches Direct Private Investment Practice

Santander Bank Launches Direct Private Investment Practice

Business Pairs Commercial Banking Customers with Potential Family Office Partners

Santander Bank Expands Its Commercial Banking Business In The Midwest Region

Santander Bank Expands Its Commercial Banking Business In The Midwest Region

Patrick Dunphy to Serve as Santander's Commercial Banking Lead based in Chicago

Santander Bank Appoints Robert Cerminaro To Commercial Banking Regional Executive For Connecticut

Santander Bank Appoints Robert Cerminaro To Commercial Banking Regional Executive For Connecticut

BOSTON, Sept. 24, 2018 /PRNewswire/ -- Santander Bank today announced that Robert Cerminaro has joined the Bank as the regional executive of Commercial Banking for Connecticut.

National Meningitis Association Urges Parents To Get Their Teens The 16 Vaccine To Help Protect Against Meningococcal Meningitis

National Meningitis Association Urges Parents To Get Their Teens The 16 Vaccine To Help Protect Against Meningococcal Meningitis

Vaccination is the best defense against meningococcal disease, yet more than half of U.S. teens have missed the Centers for Disease Control and Prevention's recommended second dose of MenACWY at age 16(1)

FDA To Review Supplemental Biologics License Application For Praluent&reg; (alirocumab) Injection As Potential Treatment To Reduce Major Adverse Cardiovascular Events

FDA To Review Supplemental Biologics License Application For Praluent® (alirocumab) Injection As Potential Treatment To Reduce Major Adverse Cardiovascular Events

* FDA also recently approved Praluent label update for some patients currently requiring LDL apheresis therapy

Cablivi&trade; (caplacizumab) Approved In Europe For Adults With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

Cablivi™ (caplacizumab) Approved In Europe For Adults With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)

- First therapeutic approved for the treatment of aTTP, a rare blood-clotting disorder

Santander Bank Confirms Termination Of OCC Consent Order

Santander Bank Confirms Termination Of OCC Consent Order

Milestone underscores continued momentum in resolving legacy issues

Santander Bank Appoints James Uehlinger As Region President For Metro New York/Northern New Jersey

Santander Bank Appoints James Uehlinger As Region President For Metro New York/Northern New Jersey

Financial Services Veteran Brings 30-Year Track Record of Leadership Success and Business Growth

Santander Holdings USA Confirms Termination Of Written Agreement With Federal Reserve Bank Of Boston

Santander Holdings USA Confirms Termination Of Written Agreement With Federal Reserve Bank Of Boston

Fourth major regulatory milestone in the last year marks most significant step yet towards resolving legacy issues

Santander Bank Expands Its Commercial Banking Business In Texas And The Southwest Region

Santander Bank Expands Its Commercial Banking Business In Texas And The Southwest Region

Joanna Ridgway Selected to Serve as Santander's Commercial Banking Lead Based in Dallas

Q2 2018 Performance Positions Sanofi For New Growth Phase

Q2 2018 Performance Positions Sanofi For New Growth Phase

PARIS, July 31, 2018 /PRNewswire/ -- Sanofi (NYSE: SNY; EURONEXT: SAN) Q2 2018 Change Change at CER H1 2018 Change Change at CER IFRS net sales reported €8,176m -5.